What pharmaceutical form is COMIRNATY LP.8.1 10 MICROGRAMOS/DOSIS DISPERSION INYECTABLE available in?

COMIRNATY LP.8.1 10 MICROGRAMOS/DOSIS DISPERSION INYECTABLE: DISPERSIÓN INYECTABLE 10 microgramos (VÍA INTRAMUSCULAR)

What are the side effects of COMIRNATY LP.8.1 10 MICROGRAMOS/DOSIS DISPERSION INYECTABLE?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Who manufactures COMIRNATY LP.8.1 10 MICROGRAMOS/DOSIS DISPERSION INYECTABLE?

Biontech Manufacturing Gmbh (ES)

OTC

COMIRNATY LP.8.1 10 MICROGRAMOS/DOSIS DISPERSION INYECTABLE

10 microgramos, DISPERSIÓN INYECTABLE

INN: VACUNA DE ARNM QUE CODIFICA LA PROTEINA DE LA ESPICULA (S) VIRAL DEL SARS-COV-2 (OMICRON LP.8.1)

Data updated: 2026-04-15

Available in:

🇨🇿🇩🇪🇬🇧🇪🇸🇸🇰

Form

DISPERSIÓN INYECTABLE

Dosage

10 microgramos

Route

VÍA INTRAMUSCULAR

Storage

—

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.